Septodont Invests in Balanced Pharma, Joins Board
Septodont, the dominant global leader in dental anesthetics, has made a strategic investment in Balanced Pharma Inc. (“BPI”) as part of an institutional.
Dentistry Today is The Nation’s Leading Clinical News Magazine for Dentists. Here you can get the latest dental news from the whole world quickly.
Septodont, the dominant global leader in dental anesthetics, has made a strategic investment in Balanced Pharma Inc. (“BPI”) as part of an institutional.
Balanced Pharma Incorporated (BPI) has announced the acquisition of rights to a promising new non-opioid injectable post-surgical pain relief drug, Enduracaine Dental, for.
The United States Patent & Trademark Office has granted Balanced Pharma, Inc. (BPI) a second patent for its cartridge technology, which enables the.
Balanced Pharma, Inc. (BPI) is pleased to announce the appointment of Alex Sadusky to the Advisory Board of Balanced Pharma. Balanced Pharma is.
More than seven out of 10 patients said they would pay extra if their dentist used a faster, less painful local anesthetic, according.